香港股市 已收市

Aspen Pharmacare Holdings Limited (APNHY)

OTC Markets OTCPK - OTC Markets OTCPK 延遲價格。貨幣為 USD。
加入追蹤清單
13.330.00 (0.00%)
收市:01:14PM EDT

Aspen Pharmacare Holdings Limited

Aspen Place
9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge
Durban
South Africa
27 31 580 8600
https://www.aspenpharma.com

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工8,612

高階主管

名稱頭銜支付行使價出生年份
Mr. Stephen Bradley Saad BCom, CA(SA)Group CEO & Executive Director1.05M1964
Mr. Sean M. CapazorioGroup CFO & Executive Director571.77k1967
Ms. Lorraine HillGroup Chief Operations Officer & Responsible Pharmacist616.2k1964
Mr. Michael Guy Attridge B.Com., CA(SA)Group Chief Advisor463.55k1961
Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBAGroup Chief Corporate Services Officer & Executive Director431.33k1975
Ms. Zizipho MmangoGroup Chief Strategic Development Officer431.27k1985
Sibongakonke NkosiInvestor Relations Manager
Mr. Trevor Julian ZimanRegional Chief Executive Officer of Asia Pacific1972
Mr. Samer KassemChief Executive Officer of Aspen Global Incorporated1975
Ms. Raeesa KhanGroup Company Secretary
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

公司管治

截至 2024年6月1日 止,Aspen Pharmacare Holdings Limited 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中:7;董事會:4;股東權利:2;現金賠償:6。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。